ORGO earnings call for the period ending March 31, 2024. Organogenesis ( ORGO -1.30%) Q1 2024 Earnings Call May 09, 2024, ...

Liver transplantation is a life-saving option for those with hepatocellular carcinoma (HCC), the most prevalent type of liver ...

Sumant Kulkarni; Analyst; Canaccord Genuity Group Inc. Samir Devani; Analyst; Rx Securities ...

Evidence from the study revealed pediatric patients with a history of cerebrovascular disease (CVD) and chronic kidney ...

This article was originally published on Cannabis.net and appears here with permission. Migraine sufferers drop prescription ...

VANCOUVER, British Columbia, May 09, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company, today reported financial results for the first ...

Q1 2024 Earnings Call Transcript May 8, 2024 Y-mAbs Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge ...

On-track for trem-cel and VCAR33ALLO clinical updates in the second half of 2024Trem-cel trial expanded to include patients ...

Senseonics, in collaboration with its commercial partner, Ascensia Diabetes Care, intends to make the Eversense CGM+RPM solution available to select population health-based systems beginning in the ...

The Phase 3 randomized, multicenter, open-label, adjudicator-blinded ORALTO trial will evaluate the efficacy and safety of MAT2203 as an oral step-down therapy following two days of treatment with ...

PRNewswire/ -- "LASTE" (LArge Stroke Therapy Evaluation), a prospective, randomized, controlled trial co-led by Professor ...

Reflow Medical, Inc., a developer of innovative devices focused on cardiovascular disease, announces completion of enrollment ...